Atrial fibrillation (AF) is the most common arrhythmia and affects over 3 million Americans, a number that is expected to rise to 12 million in 2050. AF is a major public health burden as it is associated with a five-fold increased stroke risk, doubling in dementia risk, tripling in heart failure risk, and nearly two-fold increase in mortality. Many risk factors for AF have been identified, including advancing age, male sex, hypertension, heart failure, obesity and family history. Despite the profound socioeconomic costs of AF, our understanding of the fundamental mechanisms for the arrhythmia remains largely unknown. The central goal of the candidate's research work is to use genetics to identify novel genes and pathways for AF. The candidate is a cardiac electrophysiologist with a research focus on atrial fibrillation. He has developed a cohort of patients with lone atrial fibrillation, leads an international consortium of investigators studying the genetics of atrial fibrillation, and performs laboratory work on the mechanisms of AF. Despite the initial success that candidate has had in developing a program in arrhythmia research, his clinical commitments had limited his exposure to the increasing number of fellows that he was mentoring. In 2010, the candidate received a K24 award entitled ?Mentoring in Arrhythmia Research? that enable him to reduce his clinical time and focus on mentoring of his trainees. The time afforded by this award was transformative in the candidate's research program and his academic success. Therefore, the specific aims of this competitive renewal are to provide the candidate long-term support to enable a continued reduction in his clinical commitments, and to expand the research training of fellows interested patient-oriented research in atrial fibrillation and electrophysiology. Research fellows will have ample opportunities to participate in patient-oriented research through in the MGH AF study, the AFGen Consortium, and the candidates own translational laboratory work. These research opportunities will be complemented by the extensive educational resources available at Massachusetts General Hospital, the Broad Institute, and Harvard University. Ultimately, we hope that this proposal will contribute to the development of new clinical investigators in arrhythmia research and to further our understanding of this common and morbid arrhythmia.

Public Health Relevance

Atrial fibrillation, a common, irregular heart rhythm, increases the risk of stroke and death. Despite affecting over 3 million Americans, relatively little is known about the underlying mechanisms that lead to atrial fibrillation. The goal of this proposal is to train new investigators in clinical research methods in order to ultimately learn more about the pathogenesis of this common arrhythmia.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Midcareer Investigator Award in Patient-Oriented Research (K24)
Project #
5K24HL105780-07
Application #
9321296
Study Section
NHLBI Mentored Patient-Oriented Research Review Committee (MPOR)
Program Officer
Huang, Li-Shin
Project Start
2010-12-03
Project End
2021-07-31
Budget Start
2017-08-01
Budget End
2018-07-31
Support Year
7
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02114
Choi, Seung Hoan; Weng, Lu-Chen; Roselli, Carolina et al. (2018) Association Between Titin Loss-of-Function Variants and Early-Onset Atrial Fibrillation. JAMA 320:2354-2364
Khurshid, Shaan; Choi, Seung Hoan; Weng, Lu-Chen et al. (2018) Frequency of Cardiac Rhythm Abnormalities in a Half Million Adults. Circ Arrhythm Electrophysiol 11:e006273
Hu, Ray; Morley, Michael P; Brandimarto, Jeffrey et al. (2018) Genetic Reduction in Left Ventricular Protein Kinase C-? and Adverse Ventricular Remodeling in Human Subjects. Circ Genom Precis Med 11:e001901
Roselli, Carolina; Chaffin, Mark D; Weng, Lu-Chen et al. (2018) Multi-ethnic genome-wide association study for atrial fibrillation. Nat Genet 50:1225-1233
Staerk, Laila; Wang, Biqi; Preis, Sarah R et al. (2018) Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study. BMJ 361:k1453
Prins, Bram P; Mead, Timothy J; Brody, Jennifer A et al. (2018) Exome-chip meta-analysis identifies novel loci associated with cardiac conduction, including ADAMTS6. Genome Biol 19:87
Bapat, Aneesh; Anderson, Christopher D; Ellinor, Patrick T et al. (2018) Genomic basis of atrial fibrillation. Heart 104:201-206
Khera, Amit V; Chaffin, Mark; Aragam, Krishna G et al. (2018) Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet 50:1219-1224
Weng, Lu-Chen; Preis, Sarah R; Hulme, Olivia L et al. (2018) Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial Fibrillation. Circulation 137:1027-1038
Lin, Honghuang; van Setten, Jessica; Smith, Albert V et al. (2018) Common and Rare Coding Genetic Variation Underlying the Electrocardiographic PR Interval. Circ Genom Precis Med 11:e002037

Showing the most recent 10 out of 108 publications